Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed earnings per share (EPS) estimates for FY23-24.
India top market for me, but regulatory red tape holding it back: Mark Mobius
Mark Mobius reaffirmed his bullish stance on Indian equities, despite geopolitical tensions with Pakistan. He criticized bureaucratic hurdles slowing foreign investments and urged investors to
May 15, 2025